rifabutin
Rifabutin is a semisynthetic rifamycin used in tuberculosis therapy. It inhibits DNA-dependent RNA synthesis.
Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.
Classification
rifamycin antibioticARO:3000157
- rifamycin antibiotic
ARO:3000157
Chemical structure
| Molecular formula | C46H62N4O11 |
|---|---|
| Charge | 0 |
| Average mass | 847.019 Da |
| Monoisotopic mass | 846.44151 Da |
| Source | ChEBI |
| InChIKey | ATEBXHFBFRCZMA-VXTBVIBXSA-N |
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O
InChI=1S/C46H62N4O11/c1-22(2)21-50-18-16-46(17-19-50)48-34-31-32-39(54)28(8)42-33(31)43(56)45(10,61-42)59-20-15-30(58-11)25(5)41(60-29(9)51)27(7)38(53)26(6)37(52)23(3)13-12-14-24(4)44(57)47-36(40(32)55)35(34)49-46/h12-15,20,22-23,25-27,30,37-38,41,49,52-54H,16-19,21H2,1-11H3,(H,47,57)/b13-12+,20-15+,24-14-/t23-,25+,26+,27+,30-,37-,38+,41+,45-/m0/s1
Cross-references
Source concepts
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| ARO | ARO:3000530 |
rifabutin | antibioticmech:aro-091952d65e |
2026-08-30 |
Molecular targets
rifamycin sensitive beta-subunit of RNA polymerase (rpoB) PROTEIN_COMPLEX DIRECT_BINDING_TARGET
Mechanism summary
- Clinical status
- APPROVED
Activity spectrum
| Organism | Activity | MIC | Disk diffusion | Assay | Strain | Sample/genome | Evidence |
|---|---|---|---|---|---|---|---|
| Mycobacterium tuberculosis complex | RESISTANT | — | — | CRyPTIC DST; CLIRES2020; liquid media; MGIT; MGIT960 | — |
118 source isolates 118 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | SUSCEPTIBLE | — | — | CRyPTIC DST; CLIRES2020; liquid media; MGIT; MGIT960 | — |
69 source isolates 69 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | RESISTANT | — | — | CRyPTIC DST; CLIRES2020; not specified | — |
3 source isolates 3 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | SUSCEPTIBLE | — | — | CRyPTIC DST; CLIRES2020; not specified | — |
1 source isolates 1 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | INTERMEDIATE | — | — | CRyPTIC DST; CLIRES2020; solid media | — |
1 source isolates 1 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | RESISTANT | — | — | CRyPTIC DST; CLIRES2020; solid media | — |
8 source isolates 8 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | SUSCEPTIBLE | — | — | CRyPTIC DST; CLIRES2020; solid media | — |
7 source isolates 7 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | RESISTANT | — | — | CRyPTIC DST; CLIRES2023; not specified | — |
1 source isolates 1 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | SUSCEPTIBLE | 0.12 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
249 source isolates 249 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | SUSCEPTIBLE | 0.12 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
63 source isolates 63 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | SUSCEPTIBLE | 0.12 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
45 source isolates 45 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | RESISTANT | 0.25 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
147 source isolates 147 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | RESISTANT | 0.25 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
31 source isolates 31 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | RESISTANT | 0.25 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
18 source isolates 18 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | RESISTANT | 0.5 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
106 source isolates 106 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | RESISTANT | 0.5 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
30 source isolates 30 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | RESISTANT | 0.5 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
15 source isolates 15 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | RESISTANT | 1.0 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
162 source isolates 162 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | RESISTANT | 1.0 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
41 source isolates 41 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | RESISTANT | 1.0 mg/L | — | CRyPTIC DST; CRyPTIC; liquid media; microdilution plate; UKMYC5; critical concentration 0.12 mg/L | — |
33 source isolates 33 measurements |
EvidencePage data (JSON.gz) |
Resistance mechanisms
ANTIBIOTIC_INACTIVATION 5
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| iri | ARO:3002884 | — | ||
| rgt1438 | ARO:3002883 | — | ||
| rifampin ADP-ribosyltransferase (Arr) | ARO:3000390 | — | ||
| rphA | ARO:3000444 | — | ||
| rphB | ARO:3003992 | — |
ANTIBIOTIC_TARGET_REPLACEMENT 5
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| Escherichia coli rpoB mutants conferring resistance to rifampicin | ARO:3003288 | — | ||
| Mycobacterium leprae rpoB mutations conferring resistance to rifampicin | ARO:3003284 | — | ||
| Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin | ARO:3003283 | — | ||
| Staphylococcus aureus rpoB mutants conferring resistance to rifampicin | ARO:3003285 | — | ||
| rpoB2 | ARO:3000501 | — |
ANTIBIOTIC_TARGET_PROTECTION 4
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| DnaA | ARO:3000248 | — | ||
| HelR | ARO:3007208 | — | ||
| RbpA | ARO:3000245 | — | ||
| sigma factor conferring resistance to rifampin | ARO:3000261 | — |
ANTIBIOTIC_TARGET_ALTERATION 3
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| Mycobacterium tuberculosis ponA1 mutations conferring resistance to rifabutin | ARO:3004960 | — | ||
| Mycobacterium tuberculosis rpoC mutations confer resistance to rifampicin | ARO:3004994 | — | ||
| rifampicin resistant rpoC | ARO:3004995 | — |
Curation history
-
SEEDED_FROM_SOURCES
Seeded from data/raw/ inventories (ARO, CHEBI)
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded; changed: activity_spectrum (CRYPTIC 3.4.0). Upstream retrieval date 2026-08-30, unchanged.
-
RESEEDED_FROM_SOURCES
Re-seeded; changed: activity_membership_collections (CRYPTIC 3.4.0). Upstream retrieval date 2026-08-30, unchanged.